Breaking News, Collaborations & Alliances

Willow, Suanfarma Complete Manufacturing Process for Cannabigerol

CBG is clinically tested to be safe and has been shown to act as a potent antioxidant, anti-inflammatory and anti-microbial.

Willow Biosciences and Suanfarma jointly announced that they have, along with Suanfarma’s CIPAN manufacturing site, completed the development and manufacturing process in pilot scale for the Willow-owned ingredient, Cannabigerol (CBG). The 36 m3 scaling-up production batches required for the forthcoming qualification and registration will be completed during 2023. Suanfarma’s CIPAN manufacturing site has significant expertise as a CDMO in fermentation and purification technologies under the h...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters